News
The EU's medicines regulator said it would approve the treatment for a limited group of patients, citing concerns over side effects ...
16h
InvestorsHub on MSNBeOne Medicines shares climb following positive EU backing for lung cancer therapyBeOne Medicines AG (NASDAQ:ONC) saw its stock rise 2.5% in pre-market trading after the European Medicines Agency (EMA) issued a favorable opinion on its cancer drug TEVIMBRA for early-stage lung ...
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...
3d
DPA International on MSNEMA recommends approval of additional Alzheimer's treatmentThe European Medicines Agency (EMA) cleared the way for the use of another drug to treat Alzheimer's disease on Friday.
Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...
Lilly’s appeal of an earlier, negative recommendation from a key EMA committee has worked out in its favor, and puts the drug ...
Eli Lilly and Co. won the backing of European Union regulators for its Alzheimer’s disease drug Kisunla in a specific group ...
A panel of the European medicines regulator has recommended approving an eco-friendly version of AstraZeneca's inhaler for the treatment of a chronic lung condition, the drugmaker said on Friday.
The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.
Despite a new setback for Elevidys in Europe, Roche—which markets Sarepta’s gene therapy outside the U.S.—remains committed ...
New York drugmaker Pfizer and Mainz, Germany, immunotherapy company BioNTech said the European Commission, which generally follows CHMP's advice, will now review the recommendation, with a final ...
European Medicines Agency Warns of Diabetics’ Risk Amid Ozempic Shortage Some doctors have been prescribing Ozempic for weight loss Use as slimming treatment may endanger diabetics, EMA says ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results